Literature DB >> 16775024

ADAP is dispensable for NK cell development and function.

Lindsey V Fostel1, Joanna Dluzniewska, Yoji Shimizu, Brandon J Burbach, Erik J Peterson.   

Abstract

NK cells are key mediators of the innate immune response and anti-tumor surveillance. Adhesion and degranulation-promoting adapter protein (ADAP, formerly known as SLAP-130 or Fyb) is a hematopoietic-specific adapter that is required for efficient TCR signaling and T cell activation. Herein, we examine a potential role for ADAP in NK development and function. ADAP is expressed in primary NK cells and in IL-2 stimulated lymphokine-activated killers. However, ADAP-deficient mice show no defects in NK development. Further, ADAP is dispensable for key NK functions, including cytotoxicity in response to engagement of activating receptors, cytokine production, conjugate formation and tumor suppression in vivo. These results indicate that, unlike events stimulated by TCR engagement, signaling events engaged by immunoreceptor tyrosine-based activation motif-associated and cytokine receptors on NK cells can occur independently of ADAP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775024     DOI: 10.1093/intimm/dxl063

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  16 in total

1.  NF-kappaB activation in T cells requires discrete control of IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation and IKKgamma ubiquitination by the ADAP adapter protein.

Authors:  Rupa Srivastava; Brandon J Burbach; Yoji Shimizu
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

2.  Distinct regulation of integrin-dependent T cell conjugate formation and NF-kappa B activation by the adapter protein ADAP.

Authors:  Brandon J Burbach; Rupa Srivastava; Ricardo B Medeiros; William E O'Gorman; Erik J Peterson; Yoji Shimizu
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  Signal transduction during activation and inhibition of natural killer cells.

Authors:  Carsten Watzl; Eric O Long
Journal:  Curr Protoc Immunol       Date:  2010-08

4.  Slp-76 is a critical determinant of NK-cell mediated recognition of missing-self targets.

Authors:  Kristin Lampe; Mehari Endale; Siobhan Cashman; Hao Fang; Jochen Mattner; David Hildeman; Kasper Hoebe
Journal:  Eur J Immunol       Date:  2015-05-22       Impact factor: 5.532

5.  Adhesion- and Degranulation-Promoting Adapter Protein Promotes CD8 T Cell Differentiation and Resident Memory Formation and Function during an Acute Infection.

Authors:  Jessica K Fiege; Lalit K Beura; Brandon J Burbach; Yoji Shimizu
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

Review 6.  SKAP-55, SKAP-55-related and ADAP adaptors modulate integrin-mediated immune-cell adhesion.

Authors:  Hongyan Wang; Christopher E Rudd
Journal:  Trends Cell Biol       Date:  2008-08-28       Impact factor: 20.808

7.  Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell function.

Authors:  Rebecca M May; Mariko Okumura; Chin-Jung Hsu; Hamid Bassiri; Enjun Yang; Gregory Rak; Emily M Mace; Naomi H Philip; Weiguo Zhang; Tobias Baumgart; Jordan S Orange; Kim E Nichols; Taku Kambayashi
Journal:  Blood       Date:  2013-02-13       Impact factor: 22.113

8.  The adapter protein ADAP is required for selected dendritic cell functions.

Authors:  Mauro Togni; Swen Engelmann; Dirk Reinhold; Burkhart Schraven; Annegret Reinhold
Journal:  Cell Commun Signal       Date:  2012-06-06       Impact factor: 5.712

Review 9.  Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy.

Authors:  Kamalakannan Rajasekaran; Matthew J Riese; Sridhar Rao; Li Wang; Monica S Thakar; Charles L Sentman; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2016-05-12       Impact factor: 7.561

10.  Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells.

Authors:  Kamalakannan Rajasekaran; Pawan Kumar; Kristina M Schuldt; Erik J Peterson; Bart Vanhaesebroeck; Vishva Dixit; Monica S Thakar; Subramaniam Malarkannan
Journal:  Nat Immunol       Date:  2013-09-15       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.